Discrepancies between the upper limit of vulnerability and defibrillation threshold: Prevalence and clinical predictors

Journal of Cardiovascular Electrophysiology

Volumn 14, Issue 7, 2003, Pages 728-732

  Gurevitz, Osnat T ^a   Friedman, Paul A ^a   Glikson, Michael ^b   Trusty, Jane M ^a   Ballman, Karla V ^a   Rosales, Ana G ^a   Hayes, David L ^a   Hammill, Stephen C ^a   Swerdlow, Charles D ^c  

^a MAYO CLINIC   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Defibrillation threshold; Electrical shocks; Implantable cardioverter defibrillator; Upper limit of vulnerability; Ventricular arrhythmias

Indexed keywords

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DEFIBRILLATION; DEFIBRILLATOR; ELECTRIC SHOCK; FEMALE; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MAXIMUM ALLOWABLE CONCENTRATION; PREDICTION; PREVALENCE; PRIORITY JOURNAL;

EID: 0038502014     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2003.02523.x     Document Type: Article

References (44)

1. Hwang C, Swerdlow CD, Kass RM, Gang ES, Mandel WJ, Peter CT, Chen PS: Upper limit of vulnerability reliably predicts the defibrillation threshold in humans. Circulation 1994;90:2308-2314.
2. Swerdlow CD, Ahern T, Kass RM, Davie S, Mandel WJ, Chen PS: Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators. J Am Coll Cardiol 1996;27:1112-1118.
3. Swerdlow CD, Peter CT, Kass RM, Gang ES, Mandel WJ, Hwang C, Martin DJ, Chen PS: Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability. Circulation 1997;95:1497-1504.
4. Martin DJ, Chen PS, Hwang C, Gang ES, Mandel WJ, Peter CT, Swerdlow CD: Upper limit of vulnerability predicts chronic defibrillation threshold for transvenous implantable defibrillators. J Cardiovasc Electrophysiol 1997;8:241-248.
5. Bessho R, Tanaka S: Measurement of the upper limit of vulnerability during defibrillator implantation can substitute defibrillation threshold measurement. Int J Artif Organs 1998;21:151-160.
6. Birgersdotter-Green U, Undesser K, Fujimura O, Feld GK, Kass RM, Mandel WJ, Peter CT, Chen PS: Correlation of acute and chronic defibrillation threshold with upper limit of vulnerability determined in normal sinus rhythm. J Interv Card Electrophysiol 1999;3:155-161.
7. Swerdlow CD: Implantation of cardioverter defibrillators without induction of ventricular fibrillation. Circulation 2001;103:2159-2164.
8. Singer I, van der Laken J, Edmonds HL Jr, Slater AD, Austin E, Shields CB, Kupersmith J: Is defibrillation testing safe? Pacing Clin Electrophysiol 1991;14:1899-1904.
9. Frame R, Brodman R, Furman S, Kim SG, Roth J, Ferrick K, Hollinger I, Gross J, Fisher JD: Clinical evaluation of the safety of repetitive intraoperative defibrillation threshold testing. Pacing Clin Electrophysiol 1992;15:870-877.
10. Antunes ML, Spotnitz HM, Livelli FD Jr, Steinberg JS, Bigger JT Jr: Effect of electrophysiological testing on ejection fraction during cardioverter/defibrillator implantation. Ann Thorac Surg 1988;45:315-318.
11. Van Riper DF, Horrow JC, Kutalek SP, McCormick D, Goldman SM: Mixed venous oximetry during automatic implantable cardioverter-defibrillator placement. J Cardiothorac Anesth 1990;4:453-457.
12. Steinbeck G, Dorwarth U, Mattke S, Hoffmann E, Markewitz A, Kaulbach H, Tassani P: Hemodynamic deterioration during ICD implant: Predictors of high-risk patients. Am Heart J 1994;127:1064-1067.
13. Vlay SC: Defibrillation threshold testing: Necessary but evil? Am Heart J 1989;117:499-504.
14. Meesmann M: Factors associated with implantation-related complications. Pacing Clin Electrophysiol 1992;15:649-653.
15. Borbola J, Denes P, Ezri MD, Hauser RG, Serry C, Goldin MD: The automatic implantable cardioverter-defibrillator: Clinical experience, complications, and follow-up in 25 patients. Arch Intern Med 1988;148:70-76.
16. Degroot PJ, Church TR, Mehra R, Martinson MS, Schaber DE: Derivation of a defibrillator implant criterion based on probability of successful defibrillation. Pacing Clin Electrophysiol 1997;20:1924-1935.
17. Kroll MW, Tchou PJ: Testing of implantable defibrillator functions at implantation. In Ellenbogen KA, Kay GN, Wilkoff BL, eds: Clinical Cardiac Pacing and Defibrillation. Second Edition. Philadelphia: WB Saunders Company, 2000, pp. 540-561.
18. Hurwitz JL, Hook BG, Flores BT, Marchlinski FE: Importance of abortive shock capability with electrogram storage in cardioverter-defibrillator devices. J Am Coll Cardiol 1993;21:895-900.
19. Swerdlow CD, Davie S, Ahern T, Chen PS: Comparative reproducibility of defibrillation threshold and upper limit of vulnerability. Pacing Clin Electrophysiol 1996;19:2103-2111.
20. Huang J, KenKnight BH, Walcott GP, Rollins DL, Smith WM, Ideker RE: Effects of transvenous electrode polarity and waveform duration on the relationship between defibrillation threshold and upper limit of vulnerability. Circulation 1997;96:1351-1359.
21. Fan W, Gotoh M, Chen PS: Effects of the pacing site, procainamide, and lead configuration on the relationship between the upper limit of vulnerability and the defibrillation threshold. Pacing Clin Electrophysiol 1995;18:1279-1284.
22. Behrens S, Li C, Franz MR: Effects of myocardial ischemia on ventricular fibrillation inducibility and defibrillation efficacy. J Am Coll Cardiol 1997;29:817-824.
23. Trappe HJ, Fieguth HG, Pfitzner P, Heintze J, Wenzlaff P, Kielblock B: Epicardial and nonthoracotomy defibrillation lead systems combined with a cardioverter defibrillator. Pacing Clin Electrophysiol 1995;18:127-132.
24. Vijgen J, Hull M, Carlson MD, US VENTAK P2 and P2/ENDOTAK Investigators: Predictors of implantable cardioverter defibrillator first shock efficacy: Implications for clinical practice. (Abstract) Pacing Clin Electrophysiol 1996;19:736.
25. Swerdlow CD, Martin DJ, Kass RM, Davie S, Mandel WJ, Gang ES, Chen PS: The zone of vulnerability to T wave shocks in humans. J Cardiovasc Electrophysiol 1997;8:145-154.
26. Fabiato A, Coumel P, Gourgon R, Saumont R: The threshold of synchronous response of the myocardial fibers: Application to the experimental comparison of the efficacy of different forms of electroshock defibrillation [French]. Arch Mal Coeur Vaiss 1967;60:527-544.
27. Wiggers CJ: Studies of ventricular fibrillation caused by electric shock: Cinematographic and electrocardiographic observations of natural process in dog's heart: Its inhibition by potassium and revival of coordinated beats by calcium. Am Heart J 1930;5:351-365.
28. Chen PS, Wolf PD, Dixon EG, Danieley ND, Frazier DW, Smith WM, Ideker RE: Mechanism of ventricular vulnerability to single premature stimuli in open-chest dogs. Circ Res 1988;62:1191-1209.
29. Shibata N, Chen PS, Dixon EG, Wolf PD, Danieley ND, Smith WM, Ideker RE: Influence of shock strength and timing on induction of ventricular arrhythmias in dogs. Am J Physiol 1988;255:H891-H901.
30. Fabritz CL, Kirchhof PF, Behrens S, Zabel M, Franz MR: Myocardial vulnerability to T wave shocks: Relation to shock strength, shock coupling interval, and dispersion of ventricular repolarization. J Cardiovasc Electrophysiol 1996;7:231-242.
31. Chen PS, Feld GK, Mower MM, Peters BB: Effects of pacing rate and timing of defibrillation shock on the relation between the defibrillation threshold and the upper limit of vulnerability in open chest dogs. J Am Coll Cardiol 1991;18:1555-1563.
32. Malkin RA, Idriss SF, Walker RG, Ideker RE: Effect of rapid pacing and T-wave scanning on the relation between the defibrillation and upper-limit-of-vulnerability dose-response curves. Circulation 1995;92:1291-1299.
33. Moubarak JB, Karasik PE, Fletcher RD, Franz MR: High dispersion of ventricular repolarization after an implantable defibrillator shock predicts induction of ventricular fibrillation as well as unsuccessful defibrillation. J Am Coll Cardiol 2000;35:422-427.
34. Lesigne C, Levy B, Saumont R, Birkui P, Bardou A, Rubin B: An energy-time analysis of ventricular fibrillation and defibrillation thresholds with internal electrodes. Med Biol Eng 1976;14:617-622.
35. Winfree AT: When Time Breaks Down: The Three-dimensional Dynamics of Electrochemical Waves and Cardiac Arrhythmias. Princeton: Princeton University Press, 1987.
36. Swerdlow CD, Kass RM, O'Connor ME, Chen PS: Effect of shock waveform on relationship between upper limit of vulnerability and defibrillation threshold. J Cardiovasc Electrophysiol 1998;9:339-349.
37. Topham SL, Cha YM, Peters BB, Chen PS: Effects of lidocaine on relation between defibrillation threshold and upper limit of vulnerability in open-chest dogs. Circulation 1992;85:1146-1151.
38. Malkin RA, Hoffmeister BK: Hemodynamic collapse, geometry, and the rapidly paced upper limit of ventricular vulnerability to fibrillation by T-wave stimulation. J Electrocardiol 2000;33:279-286.
39. Janse MJ, van der Steen AB, van Dam RT: Refractory period of the dog's ventricular myocardium following sudden changes in frequency. Circ Res 1969;24:251-262.
40. Cao JM, Qu Z, Kim YH, Wu TJ, Garfinkel A, Weiss JN, Karagueuzian HS, Chen PS: Spatiotemporal heterogeneity in the induction of ventricular fibrillation by rapid pacing: Importance of cardiac restitution properties. Circ Res 1999;84:1318-1331.
41. Pastore JM, Girouard SD, Laurita KR, Akar FG, Rosenbaum DS: Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation 1999;99:1385-1394.
42. Han J, Moe GK: Nonuniform recovery of excitability in ventricular muscle. Circ Res 1964;14:44-60.
43. El-Sherif N: Mechanism of ventricular arrhythmias in the long QT syndrome: On hermeneutics. J Cardiovasc Electrophysiol 2001;12:973-976.
44. Coumel P, Maison-Blanche P, Badilini F: Dispersion of ventricular repolarization: Reality? Illusion? Significance? (Editorial) Circulation 1998;97:2491-2493.